107 related articles for article (PubMed ID: 19187786)
1. Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions.
Cricca M; Venturoli S; Leo E; Costa S; Musiani M; Zerbini M
J Virol Methods; 2009 Jun; 158(1-2):180-3. PubMed ID: 19187786
[TBL] [Abstract][Full Text] [Related]
2. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions.
Matovina M; Sabol I; Grubisić G; Gasperov NM; Grce M
Gynecol Oncol; 2009 Apr; 113(1):120-7. PubMed ID: 19157528
[TBL] [Abstract][Full Text] [Related]
3. Impact of viral E2-gene status on outcome after radiotherapy for patients with human papillomavirus 16-positive cancer of the uterine cervix.
Lindel K; de Villiers EM; Burri P; Studer U; Altermatt HJ; Greiner RH; Gruber G
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):760-5. PubMed ID: 16682151
[TBL] [Abstract][Full Text] [Related]
4. The relationship between c-FLIP expression and human papillomavirus E2 gene disruption in cervical carcinogenesis.
Wang W; Wang S; Song X; Sima N; Xu X; Luo A; Chen G; Deng D; Xu Q; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Jun; 105(3):571-7. PubMed ID: 17433827
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion.
Cricca M; Venturoli S; Leo E; Costa S; Musiani M; Zerbini M
J Med Virol; 2009 Jul; 81(7):1276-82. PubMed ID: 19475620
[TBL] [Abstract][Full Text] [Related]
6. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions.
Coutlée F; Trottier H; Gagnon S; Koushik A; Richardson H; Roger M; Ferenczy AS; Franco EL
J Clin Virol; 2009 Jun; 45(2):96-9. PubMed ID: 19398216
[TBL] [Abstract][Full Text] [Related]
7. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
[TBL] [Abstract][Full Text] [Related]
8. Sites of disruption within E1 and E2 genes of HPV16 and association with cervical dysplasia.
Tsakogiannis D; Gortsilas P; Kyriakopoulou Z; Ruether IG; Dimitriou TG; Orfanoudakis G; Markoulatos P
J Med Virol; 2015 Nov; 87(11):1973-80. PubMed ID: 25959607
[TBL] [Abstract][Full Text] [Related]
9. New molecular method for the detection of human papillomavirus type 16 integration.
Cañadas MP; Darwich L; Sirera G; Cirigliano V; Bofill M; Clotet B; Videla S;
Clin Microbiol Infect; 2010 Jul; 16(7):836-42. PubMed ID: 19840031
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the E2 gene is a common and early event in the natural history of cervical human papillomavirus infection: a longitudinal cohort study.
Collins SI; Constandinou-Williams C; Wen K; Young LS; Roberts S; Murray PG; Woodman CB
Cancer Res; 2009 May; 69(9):3828-32. PubMed ID: 19401452
[TBL] [Abstract][Full Text] [Related]
11. Presence of genetic rearrangements in E1/E2 regions of episomal HPV 16 isolates from cervical carcinomas 5-8.
Dong X; Zhou W; Pfister H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):5-8. PubMed ID: 11503015
[TBL] [Abstract][Full Text] [Related]
12. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 16 variants in cervical cancer from an admixtured population in Brazil.
Junes-Gill K; Sichero L; Maciag PC; Mello W; Noronha V; Villa LL
J Med Virol; 2008 Sep; 80(9):1639-45. PubMed ID: 18649325
[TBL] [Abstract][Full Text] [Related]
14. HPV-16 E2 physical status and molecular evolution in vivo in cervical carcinomas.
Kahla S; Kochbati L; Chanoufi MB; Maalej M; Oueslati R
Int J Biol Markers; 2014 Mar; 29(1):e78-85. PubMed ID: 24170557
[TBL] [Abstract][Full Text] [Related]
15. Methylation at 3'LCR of HPV16 can be affected by patient age and disruption of E1 or E2 genes.
Filho SMA; Bertoni N; Brant AC; Vidal JPCB; Felix SP; Cavalcanti SMB; Carestiato FN; Martins LFL; Almeida LM; Moreira MAM
Virus Res; 2017 Mar; 232():48-53. PubMed ID: 28143725
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression.
Lee K; Magalhaes I; Clavel C; Briolat J; Birembaut P; Tommasino M; Zehbe I
Virus Res; 2008 Jan; 131(1):106-10. PubMed ID: 17869365
[TBL] [Abstract][Full Text] [Related]
17. Preferential sites for the integration and disruption of human papillomavirus 16 in cervical lesions.
Li H; Yang Y; Zhang R; Cai Y; Yang X; Wang Z; Li Y; Cheng X; Ye X; Xiang Y; Zhu B
J Clin Virol; 2013 Apr; 56(4):342-7. PubMed ID: 23290390
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel human papillomavirus type 16 E1 gene variant with potentially reduced oncogenicity.
Sabol I; Matovina M; Gasperov NM; Grce M
J Med Virol; 2008 Dec; 80(12):2134-40. PubMed ID: 19040290
[TBL] [Abstract][Full Text] [Related]
19. E2 and the co-activator p300 can cooperate in activation of the human papillomavirus type 16 early promoter.
Krüppel U; Müller-Schiffmann A; Baldus SE; Smola-Hess S; Steger G
Virology; 2008 Jul; 377(1):151-9. PubMed ID: 18495195
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer.
Arias-Pulido H; Peyton CL; Joste NE; Vargas H; Wheeler CM
J Clin Microbiol; 2006 May; 44(5):1755-62. PubMed ID: 16672403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
